CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 60 filers reported holding CONATUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $14,000 | -36.4% | 12,700 | 0.0% | 0.00% | – |
Q4 2018 | $22,000 | -70.3% | 12,700 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $74,000 | +37.0% | 12,700 | 0.0% | 0.00% | – |
Q2 2018 | $54,000 | -28.0% | 12,700 | 0.0% | 0.00% | -100.0% |
Q1 2018 | $75,000 | -3.8% | 12,700 | -24.4% | 0.00% | 0.0% |
Q4 2017 | $78,000 | -15.2% | 16,800 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $92,000 | – | 16,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,464,807 | $14,468,000 | 5.57% |
COURAGE CAPITAL MANAGEMENT LLC | 192,486 | $1,130,000 | 0.86% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 90,455 | $531,000 | 0.07% |
Alambic Investment Management, L.P. | 86,204 | $506,000 | 0.07% |
Kalos Management, Inc. | 30,000 | $164,000 | 0.05% |
Dynamic Technology Lab Private Ltd | 32,394 | $190,000 | 0.03% |
ELLINGTON MANAGEMENT GROUP LLC | 60,600 | $356,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 55,008 | $323,000 | 0.02% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $129,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 580,972 | $3,411,000 | 0.02% |